It improves the TMZ chemotherapy response by ROS upregulation, indicating that Trim25-mediated ubiquitination of ITPKB may be an important regulatory mechanism in the pathogenesis and treatment of GBM. The gene discussed is TRIM25; the disease is glioblastoma.